Low Dose Treatment of Ribavirin in Combination With PEG-IFN Alfa-2b [Peginterferon alfa-2b] in CHC [chronic hepatitis C] Patients With genotype1 High Viral Load and Low Body Weight.
Phase of Trial: Phase IV
Latest Information Update: 11 Apr 2017
At a glance
- Drugs Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Schering-Plough
- 13 Jan 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 13 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by Clinicaltrials.gov.